Alisporivir Completed Phase 2 Trials for Hepatitis C Viral Infection / Hepatitis C, Liver Disease / Liver Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02094443Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option